NASDAQ: JANX - Janux Therapeutics, Inc.

Altı ay boyunca karlılık: +37.66%
Sektör: Healthcare

Promosyon programı Janux Therapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on proprietary Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients suffering from cancer. Its lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2.

daha fazla ayrıntı
The company is also developing a TRACIr costimulatory bispecific product candidate against programmed death-ligand 1 and Cluster of Differentiation 28 designed to improve the anti-tumor activity of T cells. In addition, its PSMA-TRACTr is designed to target PSMA, a protein expressed in prostate cancer tumors and the vasculature of other tumors; EGFR-TRACTr is designed to target EGFR in various cancer types with multiple approved monoclonal antibodies; and TROP2-TRACTr is designed to target TROP2, a clinically validated anti-tumor target for which there is an approved anti-TROP2 antibody-drug conjugate. The company was incorporated in 2017 and is headquartered in San Diego, California.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2021-06-11
ISIN US47103J1051
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.januxrx.com
Цена ао 55.95
Günlük fiyat değişimi: -1.94% (55.17)
Haftalık fiyat değişimi: -4.8% (56.83)
Aylık fiyat değişimi: +16.62% (46.39)
3 ayda fiyat değişimi: +16.97% (46.25)
Altı ayda fiyat değişimi: +37.66% (39.3)
Yıllık fiyat değişimi: +404.19% (10.73)
3 yılda fiyat değişimi: +184.74% (19)
5 yılda fiyat değişimi: 0% (54.1)
10 yılda fiyat değişimi: 0% (54.1)
Yılbaşından bu yana fiyat değişimi: +16.62% (46.39)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 56.85 1
P/BV 1.33 9
P/E 0 0
EV/EBITDA -6.55 0
Toplam: 3.75

Yeterlik

İsim Anlam Seviye
ROA, % -15.32 0
ROE, % -16.93 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.3455 10
Toplam: 8.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 2027.11 10
karlılık Ebitda, % 1769.05 10
karlılık EPS, % 100.51 10
Toplam: 10
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
RA Capital Management, L.P. 9165652 17.74
FMR, LLC 4671213 9.04
BVF Inc. 4579818 8.87
Orbimed Advisors LLC. 3317927 6.42
Citadel Advisors Llc 3120205 6.04
Janus Henderson Group PLC 1931477 3.74
Blackrock Inc. 1762101 3.41
Adage Capital Partners GP L.L.C. 1355475 2.62
Vanguard Group Inc 979483 1.9
Geode Capital Management, LLC 408190 0.79

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
Range Cancer Therapeutics ETF 1.74852 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 0.93949 63.04 0.33
Direxion Daily S&P Biotech Bull 3x Shares 0.31451 4067.92 0.25924
Future Tech ETF 0.25252 426.34 0.8416
Principal Healthcare Innovators ETF 0.25252 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.24933 28.58 0.8565
ProShares Ultra Nasdaq Biotechnology 0.16649 51.7 0.85651
Vanguard U.S. Momentum Factor ETF 0.14 30.05 1.05834
iShares Russell 2000 Growth ETF 0.10435 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.1 23.05 0.60264
iShares ESG Aware MSCI USA Small-Cap ETF 0.05375 18.09 1.49366
Vanguard Russell 2000 ETF 0.05 17.16 1.48801
ProShares UltraPro Russell2000 0.0304 89.82 1.47873
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.0218 31.36 1.41955
Fidelity MSCI Health Care Index ETF 0.01547 3 1.46057
Humankind US Stock ETF 0.01472 18.81 1.99919
ProShares Hedge Replication ETF 0.0082 5.92 1.47892
iShares Russell 3000 ETF 0.00313 24.83 1.43482
SPDR Portfolio MSCI Global Stock Market ETF 0.00288 17.99 2.19607
Avantis U.S. Equity ETF 0.00103 23.04 1.59151
Dimensional U.S. Equity ETF 0.00061 31.53 1.3557
Dimensional US Core Equity Market ETF 0.00007 30.98 1.40618
Vanguard Russell 3000 ETF 0 31.87 1.43817



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. David Alan Campbell Ph.D. President, CEO & Director 1.04M 1960 (65 yıllar)
Mr. Byron Robinson J.D., Ph.D. Chief Strategy Officer 723k 1965 (60 yıllar)
Mr. Charles M. Winter Chief Technical Officer 590.4k 1969 (56 yıllar)
Mr. James Pennington General Counsel N/A
Ms. Brenda Van Vreeswyk Head of Human Resources N/A
Mr. Andy Hollman Meyer Chief Business Officer N/A 1984 (41 yıl)
Dr. Tommy Diraimondo Ph.D. Chief Scientific Officer N/A 1986 (39 yıllar)
Mr. Matt Whitmire Vice President of Finance
Ms. Maria Dobek Principal Accounting Officer & VP of Accounting 1989 (36 yıllar)

Adres: United States, La Jolla. CA, 11099 North Torrey Pines Road - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.januxrx.com